BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3677119)

  • 1. Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
    Gundersen S
    Cancer Treat Rep; 1987 Nov; 71(11):997-9. PubMed ID: 3677119
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
    Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
    Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
    Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
    Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B.
    Carey RW; Anderson JR; Green M; Ellison RR; Nathanson L; Kennedy BJ
    Cancer Treat Rep; 1986 Mar; 70(3):329-31. PubMed ID: 2420443
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H; Kleeberg UR
    Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group.
    Verschraegen CF; Kleeberg UR; Mulder J; Rumke P; Truchetet F; Czarnetzki B; Rozencweig M; Thomas D; Suciu S
    Cancer; 1988 Sep; 62(6):1061-5. PubMed ID: 3409184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 13. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.
    Ringborg U; Jungnelius U; Hansson J; Strander H
    Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
    Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY
    Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802
    [No Abstract]   [Full Text] [Related]  

  • 17. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W
    Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy].
    Focan C; Doalto L; Mazy V; Levi F; Bruguerolle B; Cano JP; Rahmani R; Hecquet B
    Bull Cancer; 1989; 76(8):909-12. PubMed ID: 2620124
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].
    Akazawa S; Kitagawa H; Nakagawa T; Fujiki T; Kanda Y; Futatsuki K; Sampi K; Fujita K
    Gan To Kagaku Ryoho; 1984 May; 11(5):1018-23. PubMed ID: 6539098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.